期刊文献+

109例丙型肝炎病毒感染患者合并代谢综合征的临床分析 被引量:3

Clinical analysis of 109 cases of hepatitis C virus infection In patients with the metabolic syndrome
暂未订购
导出
摘要 目的探讨丙型肝炎病毒(HCV)感染与代谢综合征(MS)的临床相关性及其与肝纤维化的关系。方法用荧光定量逆转录聚合酶反应检测样本的HCV-RNA含量;采用ELISA法检测抗-HCV,用全自动生化检测仪测定空腹血糖、甘油三酯(TG)、高密度脂蛋白(HDL-C)、谷丙转氨酶(ALT)、谷草转氨酶(AST)水平。使用全自动血细胞分析仪进行血小板计数。结果 109例HCV感染患者中,有38例高血压,51例高血糖,43例血脂紊乱,33例合并代谢综合征,与对照组相比,有显著性差异。HCV感染合并代谢综合征患者33例中,AST/ALT≥1者有13例,APRI>1.5者有15例,与HCV感染未合并代谢综合征组相比,差异有统计学意义。结论丙型肝炎病毒感染与高血糖、高血压及高血脂、代谢综合征密切相关;代谢综合征可加重丙型肝炎患者的炎症程度,可能是丙型肝炎病毒感染患者肝纤维化的促进因素。 Objective To investigate the clinical relevance and pathogenesis between the hepatitis C virus(HCV) infection and the metabolic syndrome(MS),and the relationship with liver fibrosis.Methods Fluorescence quantification PCR technology were used to detect HCV-RNA,and anti-HCV with ELISA,and fasting glucose,triglycerides(TG),high density lipoprotein(HDL-C),alanine aminotransferase(ALT),aspartate aminotransferase(AST) levels with Automatic Biochemical Detector,platelet count with automated hematology analyzer.Results 109 cases of patients with HCV infection,there are 51 cases of high glucose,38 cases of hypertension,43 cases of dyslipidemia,33 patients with metabolic syndrome.There are significant differences compared with the control group.HCV infection with metabolic syndrome in 33 cases of patients,AST/ALT≥1 has 13 cases,APRI〉1.5 has 15 cases,compared with the group of HCV infection but non-metabolic syndrome,the difference was statistically significant.Conclusion The relationship between hepatitis C virus infection and high glucose,high blood pressure and high blood lipids,metabolic syndrome is closely;metabolic syndrome in patients with hepatitis C may increase the degree of inflammation,may be a promoting factor from hepatitis C to fibrosis.
出处 《中国实验诊断学》 北大核心 2011年第11期1866-1868,共3页 Chinese Journal of Laboratory Diagnosis
关键词 丙型肝炎病毒 代谢综合征 肝炎 肝纤维化 hepatitis C virus metabolic syndrome chronic hepatitis C Liver fibrosis
  • 相关文献

参考文献1

二级参考文献37

  • 1[26]Ishak K,Baptista A,Bianchi L,Callea F,De Groote J,Gudat F,Denk H,Desmet V,Korb G,MacSween RN,Phillips M,Portmann BG,Poulsen H,Scheuer PJ,Schmid M,Thaler H.Histological grading and staging of chronic hepatitis.J Hepatol 1995; 22:696-699
  • 2[27]Rubbia-Brandt L,Quadri R,Abid K,Giostra E,Male PJ,Mentha G,Spahr L,Zarski PJ,Borisch B,Hadengue A,Negro F.Hepatocyte steatosis is a cytopathic effect of hepatitis C virus genotype 3.J Hepatol 2000; 33:106-115
  • 3[28]Rubbia-Brandt L,Leandro G,Spahr L,Giostra E,Quadri R,Male PJ,Negro F.Liver steatosis in chronic hepatitis C:a morphological sign suggesting infection with HCV genotype 3.Histopathology 2001; 39:119-124
  • 4[29]Giannini E,Ceppa P,Botta F,Mastracci L,Romagnoli P,Comino I,Pasini A,Risso D,Lantieri PB,Icardi G,Barreca T,Testa R.Leptin has no role in determining severity of steatosis and fibrosis in patients with chronic hepatitis C.Am J Gastroenterol 2000; 95:3211-3217
  • 5[30]Monto A,Alonso J,Watson JJ,Grunfeld C,Wright TL.Steatosis in chronic hepatitis C:Relative contributions of obesity,diabetes mellitus,and alcohol.Hepatology 2002; 36:729-736
  • 6[31]Perlemuter G,Sabile A,Letteron P,Vona G Topileo A,Chretien Y,Koika K,Pessayre D,Chapman MJ,Barba G,Brechot C.Hepatitis C virus core protein inhibits microsomal triglyceride transfer protein activity and very low density lipoprotein secretion:a model of viral-related steatosis.FASEB J 2002; 16:185-194
  • 7[32]Eder G,Sárosi I,Schaff Zs.Safety testing of blood products in chimpanzees.In:Eder G,Kaiser E,King FA,eds.The role of the chimpanzeein research.Basel:Karger S,1994:156-166
  • 8[33]Fujie H,Yotsuyanagi H,Moriya K,Shintani Y,Tsutsumi T Takayama T,Makuuchi M,Matsuura Y,Miyamura T,Kimura S,Koike K et al.Steatosis and intrahepatic hepatitis C virus in chronic hepatitis.JMed Virol 1999; 59:141-145
  • 9[34]Thomssen R,Bonk S,Thiele A.Density heterogeneities of hepatitis C virus in human sera due to the binding of betalipoproteins and immunoglobulins.Med Microbiol Immunol 1993; 182:329-334
  • 10[35]Serfaty L,Andreani T,Giral P,Carbonell N,Chazouilleres O,Poupon R.Hepatitis C virus induced hypobetalipoproteinaem ia:a possible mechanism for steatosis in chronic hepatitis C.J Hepatol 2001; 34:428-434

共引文献21

同被引文献16

引证文献3

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部